首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1369836篇
  免费   96876篇
  国内免费   4703篇
耳鼻咽喉   20251篇
儿科学   40708篇
妇产科学   39408篇
基础医学   191093篇
口腔科学   40359篇
临床医学   116651篇
内科学   268198篇
皮肤病学   30964篇
神经病学   108143篇
特种医学   54820篇
外国民族医学   452篇
外科学   211602篇
综合类   35225篇
现状与发展   10篇
一般理论   441篇
预防医学   94259篇
眼科学   32115篇
药学   103537篇
  27篇
中国医学   4613篇
肿瘤学   78539篇
  2018年   12968篇
  2016年   11579篇
  2015年   13372篇
  2014年   18514篇
  2013年   27067篇
  2012年   35558篇
  2011年   37563篇
  2010年   22460篇
  2009年   21510篇
  2008年   35414篇
  2007年   38426篇
  2006年   39034篇
  2005年   37763篇
  2004年   36352篇
  2003年   35263篇
  2002年   34619篇
  2001年   64351篇
  2000年   66026篇
  1999年   56038篇
  1998年   15075篇
  1997年   13849篇
  1996年   13253篇
  1995年   12510篇
  1994年   11724篇
  1992年   43035篇
  1991年   41524篇
  1990年   40737篇
  1989年   39685篇
  1988年   37117篇
  1987年   36533篇
  1986年   35000篇
  1985年   33195篇
  1984年   24893篇
  1983年   21089篇
  1982年   12683篇
  1981年   11599篇
  1979年   23949篇
  1978年   17088篇
  1977年   14851篇
  1976年   13402篇
  1975年   15281篇
  1974年   18092篇
  1973年   17578篇
  1972年   16822篇
  1971年   15723篇
  1970年   14929篇
  1969年   14352篇
  1968年   13462篇
  1967年   12022篇
  1966年   11264篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
A combined LC/RIA procedure is described for the selective determination of dexamethasone (DEX) and its prodrug dexamethasone-21-isonicotinate (DIN) in plasma. The low affinity of the employed dexamethasone antiserum for DIN (cross-reactivity less than 0.5%) allowed the direct determination of DEX in plasma extracts. For the determination of DIN, both substances of interest were separated by LC, the DIN containing fraction was collected, hydrolysed and the generated DEX was consequently assayed by radioimmunoassay. The assay detection limits were 0.1 ng ml-1 for DEX and 0.75 ng ml-1 for DIN. For both substances, inter- and intra-day variabilities (RSDs) were 6 and 12%, respectively.  相似文献   
993.
PURPOSE: This study was designed to assess pelvic bone temperature during typical treatment regimens of transurethral ultrasound thermal ablation of the prostate to establish guidelines for limiting bone heating. METHODS: Treatment with transurethral planar, curvilinear, and sectored tubular applicators was simulated using an acoustic and biothermal pelvic model that accommodates applicator sweeping, boundary temperature control, and changes in perfusion and attenuation with thermal dose to more accurately model ultrasound energy penetration. The effects of various parameters including power and frequency (5-10 MHz) on bone heating were assessed for a range of prostate cross-sections (3-5 cm) and bone distances (1-3 cm). RESULTS: All devices can produce significant bone heating (temperatures >50 degrees C, thermal dose >240 EM(43 degrees C)) without optimization of applied frequency or power for bone <3 cm from the prostate boundary. In small glands ( approximately 3 cm) increasing operating frequency of curvilinear and planar devices can increase bone temperatures, whereas the tubular applicator can be used at 10 MHz to avoid likely bone damage. In larger prostates (4-5 cm wide) increasing frequency reduces bone heating but can substantially increase treatment time. Lowering power can reduce bone temperature but may increase thermal dose by increasing treatment duration. All applicators can be used to treat glands 4-5 cm with limited bone heating by selecting appropriate power and frequency. CONCLUSIONS: Pubic bone heating during ultrasound thermal therapy of the prostate can be substantial in certain situations. Successful realization of this therapy will require patient-specific treatment planning to optimally determine power and frequency in order to minimize bone heating.  相似文献   
994.
Rapid growth in biomedical research coupled with dramatic advancement in biotechnology has significantly improved our understanding of the molecular basis involving cancer development and progression. This improvement has led to the discovery of new molecular markers for cancer diagnosis and prognosis as well as new molecular targets for cancer treatment and intervention. Continuous emergence of some new developing area in molecular profiling, new therapeutic agents, tissue microenvironment and systems biology have made significant progress in clinical oncology. Clinical research and investigation that focus on these new developments have begun to show exciting results that indicate future promises in improving patient management and survival.  相似文献   
995.
PURPOSE: Epidermal growth factor receptor is expressed in pediatric malignant solid tumors. We conducted a phase I trial of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in children with refractory solid tumors. PATIENTS AND METHODS: Gefitinib (150, 300, 400, or 500 mg/m2) was administered orally to cohorts of three to six patients once daily continuously until disease progression or significant toxicity. Pharmacokinetic studies were performed during course one (day 1 through 28). RESULTS: Of the 25 enrolled patients, 19 (median age, 15 years) were fully evaluable for toxicity and received 54 courses. Dose-limiting toxicity was rash in two patients treated with 500 mg/m2 and elevated ALT and AST in one patient treated with 400 mg/m2. The maximum-tolerated dose was 400 mg/m2/d. The most frequent non-dose-limiting toxicities were grade 1 or 2 dry skin, anemia, diarrhea, nausea, and vomiting. One patient with Ewing's sarcoma had a partial response. Disease stabilized for 8 to > or = 60 weeks in two patients with Wilms' tumor and two with brainstem glioma (one exophytic). At 400 mg/m2, the median peak gefitinib plasma concentration was 2.2 microg/mL (range, 1.2 to 3.6 microg/mL) and occurred at a median of 2.3 hours (range, 2.0 to 8.3 hours) after drug administration. The median apparent clearance and median half-life were 14.8 L/h/m2 (range, 3.8 to 24.8 L/h/m2) and 11.7 hours (range, 5.6 to 22.8 hours), respectively. Gefitinib systemic exposures were comparable with those associated with antitumor activity in adults. CONCLUSION: Oral gefitinib is well tolerated in children. Development of the drug in combination with cytotoxic chemotherapy will be pursued.  相似文献   
996.
A case of esthesioneuroblastoma with an unusual clinical and radiographic presentation is reported. The presenting symptoms as well as the computed tomographic examination were compatible with a primary intracranial mass.  相似文献   
997.
Summary. Twenty artificial periapical lesions confined to cancellous bone were prepared at the apices of first and second mandibular molars of human cadavers. The lesions emphasized removal of the lamina dura and preparation of a 'halo' lesion surrounding the root apex, plus the addition of a simulated sclerotic border. Radiographs taken before and after creation of the lesions were scored by three examiners for detectable lesions Cross-sections of the lesions were assessed for the extent of bone destruction. Periapical lesions confined to cancellous bone were detected in 80 per cent of cases, and the presence of a sclerotic border tended to enhance visualization, although not in all cases. Intentional cortical involvement also improved detection of lesions. The anatomical features of the periapical area appear to promote the visualization of lesions which might not be detected in other locations.  相似文献   
998.
The thesis of this article is that deficits in language and communication contribute to behavior problems in childhood. Mentally retarded children show a range of deficits in language and communication compared with normals; they are also at increased risk for behavior problems. The evidence suggests that these deficits are quantitative rather than qualitative. In addition, these linguistic deficits may contribute independently to the development of behavior disorders insofar as the linguistic deficit interferes with the child's ability to make himself understood or to understand others.  相似文献   
999.
In defining the linear extent of a malignant tumor in a long bone, radiographs, computerized tomography, and scintigraphy are routinely employed, especially when non-ablative surgery is being considered. The drawbacks of these modalities in defining the true intracompartmental extent of disease within a bone can largely be overcome with the use of magnetic resonance imaging. We did a prospective analysis of magnetic resonance imaging in sixteen consecutive patients with a primary malignant tumor of a long bone, and it showed that this modality has clinical promise of being more precise than the other modalities in defining the true proximal and distal extent of a tumor in a long bone. Coronal images permit easier planning of surgical techniques for salvage of a limb using an allograft than do a multiplicity of transverse images.  相似文献   
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号